Cargando…
miRNA-342 suppresses renal interstitial fibrosis in diabetic nephropathy by targeting SOX6
Diabetic kidney disease (DKD) is one of the major microvascular complications in patients with type 1 and/or type 2 diabetes, the first cause of end-stage renal disease (ESRD) in several countries and regions. However, the pathogenesis of DKD and the mechanisms through which it leads to ESRD remain...
Autores principales: | Jiang, Zhen-Huan, Tang, Yun-Zhao, Song, Hong-Na, Yang, Min, Li, Bin, Ni, Chang-Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889927/ https://www.ncbi.nlm.nih.gov/pubmed/31746345 http://dx.doi.org/10.3892/ijmm.2019.4388 |
Ejemplares similares
-
Obstructive nephropathy and molecular pathophysiology of renal interstitial fibrosis
por: Nørregaard, Rikke, et al.
Publicado: (2023) -
Research progress on the mechanism of renal interstitial fibrosis in obstructive nephropathy
por: Wang, Kangning, et al.
Publicado: (2023) -
miR-342-3p Inhibits Acute Myeloid Leukemia Progression by Targeting SOX12
por: Wang, Ying, et al.
Publicado: (2022) -
MiRNA-200b level in peripheral blood predicts renal interstitial injury in patients with diabetic nephropathy
por: Chen, Tingfang, et al.
Publicado: (2023) -
Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease
por: Montag, Judith, et al.
Publicado: (2009)